To comprehensively assess the extent of CDKN2A/B loss and determine whether it is predominantly associated with homozygous or heterozygous deletion or whether it exhibits a heterogeneous distribution across tumor samples, we conducted an evaluation of all stereotactically obtained biopsies from IDH-mutant tumors (Extended Data Fig. 6d). This evidence concerns the gene CDKN2A and neoplasm.